Latest news : Fifty 1 Labs, Inc.

10/08	Fifty 1 Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI
10/08	Fifty 1 Labs, Inc. Reports Earnings Results for the Full Year Ended June 30, 2025	CI
05/01	Fifty 1 Labs, Inc. Announces CEO Changes	CI
14/25/14	Fifty 1 Labs, Inc. Announces the Completion of the Largest and Most Comprehensive Study of Sickle Cell Disease	CI
10/25/10	Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling 50 1 Labs, Inc. Toward $50 Million Valuation	CI
30/25/30	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chairman of the Board	CI
30/25/30	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chief Executive Officer	CI
30/25/30	The Fifty 1 Labs Biosentry Division Will Develop State-Of-The-Art Biohazard Sensing Sensors Capable of Detecting Pathogens	CI
30/25/30	UAV Corp. Announces Strategic Partnership with 50 1 Labs, Inc	CI
08/25/08	Uav Corp And Genetic Networks Announce Strategic Collaboration	RE
20/25/20	Fifty 1 Labs, Inc. Appoints Gennaro D'Urso as CEO	CI
20/25/20	Fifty 1 Labs, Inc. Appoints Gennaro D'urso as Chairman	CI
20/25/20	Fifty 1 Labs, Inc. acquired Genetic Networks, LLC for $0.02 million.	CI

More news

Press Releases: Fifty 1 Labs, Inc.

07/08	Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform	AQ
10/07	Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth	AQ
15/04	Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health	AQ
14/04	Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market	AQ
05/01	Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace	AQ

More press releases

Managers and Directors: Fifty 1 Labs, Inc.

Manager	Title	Age	Since
Pritpaul Singh Arora CEO	Chief Executive Officer	47	-
Brandon Spikes PSD	President	-	-
Alind Gupta CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Robert Clark BRD	Director/Board Member	49	30/04/2025
Brandon Spikes CHM	Chairman	-	12/07/2023
Curtis Young BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FIFTY 1 LABS, INC.	0.00%	0.00%	-89.29%	-98.50%	4L
LONZA GROUP AG	+1.09%	+5.26%	+4.52%	+23.38%	5.16TCr
REVOLUTION MEDICINES, INC.	-1.07%	+2.82%	+465.96%	+570.70%	4.49TCr
IQVIA HOLDINGS INC.	+1.47%	+9.79%	+35.92%	+20.21%	4.28TCr
BEONE MEDICINES AG	+1.44%	+7.77%	+19.38%	+84.65%	4.26TCr
CELLTRION, INC.	-0.93%	-4.33%	+16.18%	+55.82%	3.18TCr
MEDPACE HOLDINGS, INC.	+1.32%	+7.30%	+33.89%	+148.53%	1.73TCr
ASCENDIS PHARMA A/S	-0.60%	+1.93%	-	-	1.66TCr
EUROFINS SCIENTIFIC SE	+0.03%	+3.41%	+6.55%	+29.84%	1.48TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	+5.41%	+82.40%	+46.13%	1.41TCr
Average	+0.40%	+3.99%	+63.95%	+97.86%	2.76TCr
Weighted average by Cap.	+0.49%	+4.72%	+99.57%	+141.38%

See all sector performances

Fifty 1 Labs, Inc. is a Nevada-based holding company focused on health, wellness, and biotech through AI-driven drug repurposing and functional medicine. The Company operates subsidiaries including Fifty1 AI Labs LLC and 51 Labs LLC, which focus on personalized medicine, sports nutrition, and advanced therapeutics. Fifty1 AI Labs LLC delivers transformative solutions for patients and shareholders. 51 Labs LLC offers a line of supplements including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies designed to enhance athletic performance, recovery, and overall health.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
21/26/21	$0.000300	0.00%	32,78,780
20/26/20	$0.000300	0.00%	28,79,598
19/26/19	$0.000300	0.00%	25,000
18/26/18	$0.000300	0.00%	18,10,000
17/26/17	$0.000300	0.00%	1,22,73,306

Delayed Quote OTC Markets

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets 09:19:26 21/08/2026 pm IST			5-day change	1st Jan Change
0.000300 ^USD	0.00%		0.00%	-40.00%

Market Cap	3L 2L 2L 2L 4L 2.69Cr 4L 26.66L 10.39L 1.35Cr 10.57L 10.34L 4.48Cr	P/E 2009	-0.05x	P/E 2010	-0.01x
Enterprise Value	1.26Cr 1.08Cr 1.01Cr 92.11L 1.73Cr 120.12Cr 1.75Cr 12Cr 4.64Cr 60Cr 4.71Cr 4.61Cr 199.59Cr	EV / Sales 2009	1.86x	EV / Sales 2010	2.41x
Free-Float	57.9%	Yield 2009 *	-	Yield 2010	-

Current month	-25.00%
1 month	-50.00%
3 months	-25.00%
Current year	-40.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.05
5 years	0		0.23
10 years	0		0.23

	2009	2010
Net sales	54.12L 46.36L 43.37L 39.7L 74.51L 52Cr 75.5L 5.12Cr 2Cr 26Cr 2.03Cr 1.99Cr 86Cr	51.07L 43.74L 40.93L 37.47L 70.31L 49Cr 71.24L 4.84Cr 1.89Cr 25Cr 1.92Cr 1.88Cr 81Cr
Net income	-22.32L -19.12L -17.89L -16.37L -30.73L -21Cr -31.13L -2.11Cr -82.41L -11Cr -83.79L -81.97L -35Cr	-18.94L -16.23L -15.18L -13.9L -26.08L -18Cr -26.43L -1.79Cr -69.95L -9.1Cr -71.13L -69.58L -30Cr
Net Debt	99.56L 85.28L 79.8L 73.04L 1.37Cr 95Cr 1.39Cr 9.43Cr 3.68Cr 48Cr 3.74Cr 3.66Cr 158.27Cr	1.23Cr 1.05Cr 98.37L 90.04L 1.69Cr 117.43Cr 1.71Cr 12Cr 4.53Cr 59Cr 4.61Cr 4.51Cr 195.11Cr

Fifty 1 Labs, Inc. Share Price

Stocks

FITY

US2104931025

Biotechnology & Medical Research

Valuation: Fifty 1 Labs, Inc.

Chart: Fifty 1 Labs, Inc.

Latest news : Fifty 1 Labs, Inc.

Press Releases: Fifty 1 Labs, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Fifty 1 Labs, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes